Get the app!
Back to Trades

Ros Matthew E

Chief Operating OfficerCIK 0001461613

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Across 2 filings between 2026, Ros Matthew E, Chief Operating Officer, has disclosed $0 in transactions — all concentrated in Jasper Therapeutics, Inc. (JSPR). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Jul 22JSPR
Jasper Therapeutics, Inc.
Ros Matthew EChief Operating OfficerOther$0
Jul 22JSPR
Jasper Therapeutics, Inc.
Ros Matthew EChief Operating OfficerOther$0

2 filings